Original
Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease
Jing Qin, Qiongqiong Yang, Xueqing Tang, Wenfang Chen, Zhibin Li, Haiping Mao, Zongpei Jiang, Fengxian Huang and Xueqing Yu
Price
42.00 $
Volume 79 (2013) p. 37 - 44
Abstract
Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease
Jing Qin1,2*, Qiongqiong Yang1,2*, Xueqing Tang1,2, Wenfang Chen3, Zhibin Li4, Haiping Mao1,2, Zongpei Jiang1,2, Fengxian Huang1,2 and Xueqing Yu1,2
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 2Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, 3Department of Pathology and 4Epidemiology and Clinical Research Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
*Both of the authors contributed equally to this work.
Objective: To analyze the clinicopathological features and therapeutic response of nephrotic IgA nephropathy (IgAN) patients with minimal-change disease (MCD). Methods: 62 nephrotic IgAN patients were enrolled between January 2002 and December 2008, and divided into two groups including Group A: patients with MCD-like pathological features, and Group B with non-MCD pathologic pattern. The clinicopathological features, treatments, and responses were then analyzed. Results: 13 (21.0%) patients exhibited MCD-like pathological changes. Patients in Group A presented more prominent proteinuria, hypoalbuminemia but higher hemoglobin and no incidence of renal insufficiency compared to Group B (p < 0.05). 62 patients were treated with corticosteroid, and the complete remission rate in Group A is higher than that in Group B (84.6% vs. 34.7%, p = 0.008), but the relapse rate is much higher in Group A (53.8% vs. 20.4%, p = 0.03). 21 patients were treated combining with immunosuppressant due to unresponsiveness or relapse, which yielded a high re-remission rate in Group A (100%). After follow-up of 53.9 ± 26.9 months, the 5-year renal survival rate is higher in Group A (100%) than that in Group B (84.7%), but no significant difference was observed (p = 0.24). Conclusions: MCD-like pathological changes exist in quite a few nephrotic IgAN patients. These IgAN patients responded well to corticosteroid monotherapy but had a higher rate of relapse. Though manifesting with severe nephrotic symptoms, they tended to have a favorable clinical outcome probably due to the minimal pathological changes. Nevertheless, larger sample size and longer follow-up periods are needed for better understanding of the disease.Correspondence to:
Dr. Xueqing Yu
Department of Nephrology
The First Affiliated Hospital
Sun Yat-sen University
Guangzhou 510080, China
Email: [email protected]
Original
Clinicopathologic features of IgA nephropathy patients with different levels of proteinuria
Zhen Ai, Ricong Xu, Wenting Liu, Qian Zhou, Bin Li, Fengxian Huang, Xueqing Yu, and Qiongqiong Yang
Price
42.00 $
Volume 86 (2016) p. 35 - 41
Abstract
Clinical Nephrology, Vol. 86 – No. 1/2016 (35-42)
Clinicopathologic features of IgA nephropathy patients with different levels of proteinuria
Zhen Ai1#2, Ricong Xu1#2, Wenting Liu1#2, Qian Zhou3, Bin Li3, Fengxian Huang1#2, Xueqing Yu1#2, and Qiongqiong Yang1#2
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 2Key Laboratory of Nephrology, Ministry of Health and Guangdong Province, and 3Epidemiology Research Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Aims: To investigate the clinicopathologic features of IgA nephropathy (IgAN) patients with different levels of proteinuria and its clinical significance. Methods: This was a single-center retrospective cohort study. Patients with biopsy-proven primary IgAN were enrolled from January 2006 to December 2011 in The First Affiliated Hospital of Sun Yat-sen University, divided into six groups based on proteinuria at biopsy (≤ 0.30 g/d, 0.31 – 0.50 g/d, 0.51 – 1.00 g/d, 1.01 – 2.00 g/d, 2.01 – 3.00 g/d, and > 3.00 g/d). Demographic and clinicopathologic data were collected and analyzed. Results: 1,413 patients were enrolled in this study, with the median proteinuria being 0.61 g/d (interquartile range 0.30 – 1.29). Patients with proteinuria > 0.50 g/d showed significant differences in their clinicopathologic characteristics with higher prevalence of hypertension, hypoalbuminemia, hyperuricemia, hypercholesterolemia and hypertriglyceridemia, worse renal function, higher proportions of segmental glomerulosclerosis, tubular atrophy/interstitial fibrosis, and interstitial inflammation. Even the patients with proteinuria 0.31 – 0.50 g/d exhibited higher uric acid, lower total serum protein and albumin, higher proportions of crescents, and global glomerulosclerosis. Furthermore, multiple risk factors linear regression analysis has shown that there were significant associations between proteinuria and serum albumin, uric acid, total cholesterol, triglyceride, systolic blood pressure, degrees of segmental glomerulosclerosis, proportions of crescents, and global glomerulosclerosis. Conclusion: Clinicopathologic features were significantly worse in IgAN patients with increasing of proteinuria.Correspondence to:
Qiongqiong Yang MD, PhD, Professor of Medicine
Department of Nephrology, The First Affiliated Hospital
Sun Yat-sen University
58th Zhongshan Road II, Guangzhou 510080, China
Email: [email protected]
Original
The prevalence and risk factors of abnormal circadian blood pressure in patients with IgA nephropathy
Shanshan Zhou, Junzhou Fu, Mingjing Liu, Shicong Yang, Qian Zhou, Xueqing Yu, and Qiongqiong Yang
Price
42.00 $
Volume 88 (2017) p. 344 - 353
Abstract
Clinical Nephrology, Vol. 88 – No. 6/2017 (344-353)
The prevalence and risk factors of abnormal circadian blood pressure in patients with IgA nephropathy
Shanshan Zhou1#2#5, Junzhou Fu5, Mingjing Liu1#2, Shicong Yang3, Qian Zhou4, Xueqing Yu1#2, and Qiongqiong Yang1#2
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 2Key Laboratory of Nephrology, Ministry of Health, Guangzhou, 3Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, 4Epidemiology Research Unit, The First Affiliated Hospital, Sun Yat-sen University, and 5Department of Nephrology, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, China
Aims: To investigate the prevalence and risk factors of abnormal circadian blood pressure (BP) rhythm among IgA nephropathy (IgAN) patients. Materials and methods: 375 Chinese IgAN patients with biopsy-proven primary IgAN were recruited from June 2013 to December 2014 and divided into four groups based on circadian BP rhythm (dippers, non-dippers, reversed dippers, and extreme dippers) measured by 24-hour ambulatory BP monitoring. Demographic and clinicopathologic data were collected and analyzed. Results: The prevalence of abnormal circadian BP was 84% (315/375) in all the participants, accounting for 82.4% of the normotensive patients and 86.1% of the hypertensive patients. The prevalence increased with the decline of estimated glomerular filtration rate (eGFR) in IgAN patients. The non-dipper pattern was most frequent (63.8%, 201/315) in this population, followed by the reversed-dipper (27.3%, 86/315), and then the extreme-dipper pattern (8.9%, 28/315). Multivariate logistic regression analysis revealed that the eGFR (odds ratio (OR) = 0.64, 95% conficence interval (CI): 0.45 – 0.93, p = 0.037), serum uric acid (OR = 1.60, 95% CI: 1.01 – 2.54, p = 0.014), and small vessel hyalinosis (OR = 2.17, 95% CI: 1.14 – 4.11, p = 0.044) were independently associated with abnormal circadian BP rhythm. Conclusion: Abnormal circadian BP rhythm was common in IgAN patients and occurred in the early stages of chronic kidney disease. Low eGFR, high serum uric acid, and small vessel hyalinosis increased risk of abnormal BP rhythm in IgAN patients.
Correspondence to:
Qiongqiong Yang, PhD,
Department of
Nephrology
The First Affiliated Hospital,
Sun Yat-sen University
58Zhongshan Road II, Guangzhou 510080, China
Email: [email protected]
Original
Long-term renal outcomes of IgA nephropathy presenting with different levels of proteinuria
Zhen Ai, Qian Zhou, Fengxian Huang, Qiongqiong Yang, and Xueqing Yu
Price
42.00 $
Volume 94 (2020) p. 290 - 296
Abstract
Clinical Nephrology, Vol. 94 – No. 6/2020 (290-296)
Long-term renal outcomes of IgA nephropathy presenting with different levels of proteinuria
Zhen Ai1#2, Qian Zhou3, Fengxian Huang1#2, Qiongqiong Yang1#2, and Xueqing Yu1#2
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 2Key Laboratory of National Health Commission, Key Laboratory of Guangdong Province, and 3Clinical Trials Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Aims: Proteinuria is a strong prognostic factor in IgA nephropathy (IgAN). However, the risk threshold of proteinuria for kidney disease progression remains in debate. This study aimed to evaluate the risk of different levels of proteinuria on renal outcomes in Chinese patients with IgAN.
Materials and methods: Patients with biopsy-proven primary IgAN were recruited and divided into four groups based on their proteinuria levels: ≤ 0.30 g/d, 0.31 – 0.50 g/d, 0.51 – 1.00 g/d, and > 1.00 g/d. The primary outcomes were composed by doubling of baseline serum creatinine (Scr) and end-stage renal disease (ESRD, defined as eGFR < 15 mL/min/1.73m2, initiation of dialysis or transplantation).
Results: A total of 921 IgAN patients were enrolled in this study. During a median follow-up duration of 48 (34 – 62) months, higher risks of doubling of baseline Scr developed in patients with proteinuria 0.31 – 0.50 g/d (HR = 2.87, p = 0.04), 0.51 – 1.00 g/d (HR = 4.26, p = 0.002), and > 1.00 g/d (HR = 14.56, p < 0.001), while increased risks for ESRD were observed in patients with proteinuria 0.51 – 1.00 g/d (HR = 3.00, p = 0.02) and > 1.00 g/d (HR = 13.03, p < 0.001) in unadjusted Cox regression models. After adjusted for potential confounders, proteinuria 0.31 – 0.50 g/d (HR = 3.70, p = 0.04), 0.51 – 1.00 g/d (HR = 3.67, p = 0.02), and > 1.00 g/d (HR = 8.20, p < 0.001) remained to be significantly associated with higher risks of doubling of Scr, while only those with proteinuria > 1.00 g/d (HR = 6.04, p = 0.001) exhibited a markedly increased risk of ESRD.
Conclusion: Patients with proteinuria levels > 0.30 g/d already have a higher risk of doubling of baseline Scr, suggesting the necessity of early intervention in patients presenting with minimal proteinuria.Correspondence to:
Prof. Xueqing Yu, MD, PhD
Department of Nephrology
The First Affiliated Hospital, Sun Yat-sen University
58th Zhongshan Road II, Guangzhou,
Guangdong 510080, China
Email: [email protected]